NI
BMY icon

Nepsis Inc’s Bristol-Myers Squibb BMY Stock Holding History

Nepsis Inc’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Sell
258,510
-3,672
-1% -$211K 5.05% 8
2026
Q1 		$15.9M Sell
262,182
-11,967
-4% -$698K 5.33% 7
2025
Q4 		$14.8M Buy
274,149
+90,852
+50% +$4.37M 4.57% 11
2025
Q3 		$8.27M Sell
183,297
-30,221
-14% -$1.41M 2.62% 21
2025
Q2 		$9.88M Sell
213,518
-11,288
-5% -$554K 2.75% 22
2025
Q1 		$13.7M Buy
+224,806
New +$13.1M 3.39% 18
2024
Q4 		– Sell
-70,768
Closed -$3.66M – 28
2024
Q3 		$3.66M Buy
70,768
+65,078
+1,144% +$3.05M 0.87% 26
2024
Q2 		$236K Sell
5,690
-230,591
-98% -$10.3M 0.06% 28
2024
Q1 		$12.8M Buy
236,281
+30,099
+15% +$1.53M 3.47% 17
2023
Q4 		$10.6M Sell
206,182
-31,894
-13% -$1.67M 3.01% 19
2023
Q3 		$13.8M Buy
238,076
+30,192
+15% +$1.85M 4.23% 15
2023
Q2 		$13.3M Buy
207,884
+3,270
+2% +$219K 4.1% 12
2023
Q1 		$14.2M Buy
204,614
+20,492
+11% +$1.45M 4.72% 9
2022
Q4 		$13.2M Buy
184,122
+4,943
+3% +$373K 4.44% 8
2022
Q3 		$12.7M Sell
179,179
-2,373
-1% -$172K 4.6% 9
2022
Q2 		$14M Buy
181,552
+8,459
+5% +$644K 4.77% 7
2022
Q1 		$12.6M Sell
173,093
-76,724
-31% -$5.15M 3.77% 17
2021
Q4 		$15.6M Buy
249,817
+32,465
+15% +$1.9M 4.52% 9
2021
Q3 		$12.9M Buy
217,352
+33,324
+18% +$2.19M 4.05% 13
2021
Q2 		$12.3M Sell
184,028
-2,790
-1% -$182K 3.9% 13
2021
Q1 		$11.8M Buy
186,818
+41,815
+29% +$2.6M 3.73% 13
2020
Q4 		$8.99M Buy
145,003
+6,997
+5% +$430K 3.27% 14
2020
Q3 		$8.32M Buy
138,006
+22,833
+20% +$1.37M 3.99% 9
2020
Q2 		$6.77M Buy
+115,173
New +$6.89M 3.28% 16

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nepsis Inc's BMY Position: Q2 2026 in Review

Nepsis Inc reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, selling an estimated $211K and leaving 258,510 shares worth $14.9M. The position accounts for 5.05% of the portfolio, ranked #8.

Nepsis Inc first reported a position in BMY in Q2 2020 and has held it in 24 quarters since. The position peaked at $15.9M in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Nepsis Inc held 258,510 shares of Bristol-Myers Squibb worth $14.9M as of Q2 2026.
  • Nepsis Inc sold 3,672 Bristol-Myers Squibb shares in Q2 2026, an estimated $211K.
  • Bristol-Myers Squibb made up 5.05% of Nepsis Inc's portfolio in Q2 2026, its #8 holding.
  • Nepsis Inc first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 24 quarters since.
  • Nepsis Inc's Bristol-Myers Squibb position peaked at $15.9M in Q1 2026.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.